|

Screening Women With Prior HPV for Anal Neoplasia

RECRUITINGN/ASponsored by Icahn School of Medicine at Mount Sinai
Actively Recruiting
PhaseN/A
SponsorIcahn School of Medicine at Mount Sinai
Started2022-03-02
Est. completion2027-01
Eligibility
Age35 Years+
SexFEMALE
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →

NCT05217940

Summary

The goal of this single arm trial is to prospectively evaluate screening methods for anal cancer precursors in HIV uninfected women with a history of lower genital tract neoplasias and cancers.

Eligibility

Age: 35 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Women with a history of pathologically proven high-grade genital HPV-associated neoplastic disease (cervical intraepithelial neoplasia 2+, vulvar intraepithelial neoplasia 2+, or vaginal intraepithelial neoplasia 2+, or history of non-metastatic cervical, vaginal or vulvar cancer)
* Documented HIV seronegativity
* Aged 35 years and older
* Seen in the Mount Sinai Health System (MSHS) or the Harris Health System (HHS) in Houston
* English or Spanish speaking

Exclusion Criteria:

• prior history or high resolution anoscopy

Conditions4

CancerEarly Stage Lower Genital Tract CancersHPV-related Anal NeoplasiasHPV-related Lower Genital Tract Neoplasias

Locations3 sites

New York

1 site
Icahn School of Medicine at Mount Sinai
New York, New York, 10029
Nadia M Zubair, MPHnadia.zubair@mountsinai.org

South Carolina

1 site
Medical University of South Carolina
Charleston, South Carolina, 29425
Ashish Deshmukh, PhD

Texas

1 site
University of Texas M D Anderson Cancer Center
Houston, Texas, 77030
Elizabeth ChiaoEYChiao@mdanderson.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.